Mahinay, Joella Mae S.
HRN: 18-62-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/19/2023
IVT
1.5g
IVT Now ANST Then Q8
G2P1 (1000) 42 2/7 Weeks AOG By LMP; T/C Meconium Stained Amniotic Fluid Via UTZ
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes